Monday, October 25, 2010: 7:00 AM
Sheraton Hall E/F (Sheraton Centre Toronto Hotel)
* Candidate for the Lee B. Lusted Student Prize Competition
Click here to view Poster Number Acronyms
Poster Board / Category
3
GLH
*
HUMAN PAPILLOMAVIRUS TESTING FOR THE DETECTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA: A SYSTEMATIC REVIEW
Emily Burger, BSBA1, Hege Kornor, PhD2, Marianne Gjertsen, MD, PhD2, Vigdis Lauvrak, ScD2 and Ivar Sønbø Kristiansen, MD, PhD1, (1)University of Oslo, Oslo, Norway, (2)The Norwegian Knowledge Centre for the Health Services, Oslo, Norway
4
QMA
MUTUAL INFORMATION ANALYSIS USED TO DETERMINE MOST INFORMATIVE FEATURES IN BREAST CANCER DIAGNOSIS
Yirong Wu, PhD1, Elizabeth S. Burnside, MD, MPH, MS1, Oguzhan Alagoz, PhD1, Mehmet U.S. Ayvaci, MS1, David Page, PhD1 and Ross Shachter, PhD2, (1)University of Wisconsin-Madison, Madison, WI, (2)Stanford University, Stanford, CA
5
QMA
A REVIEW AND META-ANALYSIS OF COLORECTAL CANCER UTILITIES
Sandjar Djalalov, PhD, St. Michael's Hospital, Toronto, ON, Canada, George Tomlinson, PhD, University of Toronto, Toronto, ON, Canada and Jeffrey Hoch, PhD, Cancer Care Ontario, Toronto, ON, Canada
6
QMA
HOW MUCH NEGATIVE MARGIN IS ENOUGH FOR PATIENTS WITH DUCTAL CARCINOMA IN SITU RECEIVING BREAST CONSERVING SURGERY WITH OR WITHOUT RADIOTHERAPY? A BAYESIAN META-ANALYSIS
Shi-Yi Wang, MD, MS, Tatyana A. Shamliyan, MD, Hawre Jalal, MD, MS, Beth Virnig, PhD, MPH, Robert L. Kane, MD and Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN
7
QMA
IS THERE A DIFFERENCE BETWEEN ORGANIC AND CONVENTIONAL ANIMAL PRODUCTS? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
Crystal M. Smith-Spangler, MD1, James C. Bavinger, BA2, Grace E. Hunter, BA2, Vandana Sundaram, MPH1, Paul Eschbach2, Dena M. Bravata, MD, MS2 and Margaret L. Brandeau, PhD2, (1)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (2)Stanford University, Stanford, CA
8
QMA
*
CARE COORDINATION: WHAT WORKS? MAKING SENSE OF A VAST LITERATURE VIA A SYSTEMATIC REVIEW OF REVIEWS
Crystal M. Smith-Spangler, MD1, Vandana Sundaram, MPH1, Lauren Albin, BS2, Douglas K. Owens, MD, MS1 and Kathryn M. McDonald, MM2, (1)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (2)Stanford University, Stanford, CA
9
HSP
*
DEVELOPMENT AND VALIDATION OF A DECISION BURDEN SCALE
Anouk M. Knops, MSc, Dirk T. Ubbink, MD, PhD, Eef J.L. van Duin, MSc, Quinten Telkamp, BSc and Astrid Goossens, PhD, Academic Medical Center, Amsterdam, Netherlands
11
QMA
THE IMPACT OF INCREASING DEGREE AND DURATION OF OBESITY AMONG US BIRTH COHORTS ON TYPE 2 DIABETES TRENDS IN THE US
Joyce Lee, MD, MPH, Achamyeleh Gebremariam, MS, Matthew Davis, MD, MAPP, Lisa Prosser, PhD and Sandeep Vijan, MD, University of Michigan, Ann Arbor, MI
14
HTA
*
RADIATION ASSOCIATED WITH CT-GUIDED ABLATION OF RENAL TUMORS: EFFECTS ON PROJECTED LIFE EXPECTANCY
Jonathan D. Eisenberg, BA, Pari V. Pandharipande, MD, MPH, Debra A. Gervais, MD, Michael E. Gilmore, MBA and G. Scott Gazelle, MD, MPH, PhD, Massachusetts General Hospital, Boston, MA
15
HTA
*
WHICH MEN WITH LOW-RISK PROSTATE CANCER SHOULD BE TREATED?
David Liu, MPH, MS1, Harold P. Lehmann, MD, PhD2, Kevin D. Frick, PhD3 and H. Ballentine Carter, MD1, (1)Johns Hopkins University School of Medicine, Baltimore, MD, (2)Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, (3)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
16
HTA
THE COST-EFFECTIVENESS OF BIOLOGICS IN POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS PATIENTS UNRESPONSIVE TO DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
Wendy J. Ungar, PhD, Vania Costa, MSc, Rebecca Hancock-Howard, PhD, Brian M. Feldman, MD, MSc, FRCPC and Ronald M. Laxer, MD, FRCPC, The Hospital for Sick Children, Toronto, ON, Canada
18
HTA
*
COST EFFECTIVENESS OF SCREENING FOR ACUTE HIV AND HCV INFECTION IN INJECTION DRUG USERS
Lauren E. Cipriano, BSc, BA, PhD Candidate1, Gregory S. Zaric, PhD2, Douglas K. Owens, MD, MS3 and Margaret L. Brandeau, PhD1, (1)Stanford University, Stanford, CA, (2)University of Western Ontario, London, ON, Canada, (3)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
19
HTA
HEALTH ECONOMIC EVALUATION OF INTRAVENOUS THROMBOLYTIC TREATMENT WITHIN 3 HOURS AND BETWEEN 3 AND 5 HOURS AFTER ONSET OF ACUTE ISCHEMIC STROKE
Vida Hamidi, Ph.D, Torbjørn Wisløff, M.Sc., Tove Ringerike, Ph.D, Ingrid Harboe and Marianne Klemp, MD, PhD, Norwegian Knowledge Centre for the Health Services, Oslo, Norway
21
HTA
THE A6 CYCLE: A METHOD FOR IDENTIFYING EVIDENCE-BASED LABORATORY MEDICINE BEST PRACTICES AND A TECHNOLOGY ASSESSMENT VALIDATION
Edward B. Liebow, PhD1, Susan R. Snyder, PhD, MBA2, Robert H. Christenson, PhD3, Colleen Shaw, MPH2, James H. Derzon, PhD4, Robert S. Black, MPH5, Paul Epner, MEd6 and Diana Mass, MA, MT(ASCP)7, (1)Battelle Memorial Institute, Seattle, WA, (2)Centers for Disease Control and Prevention, Atlanta, GA, (3)University of Maryland School of Medicine, Baltimore, MD, (4)Battelle Memorial Institute, Arlington, VA, (5)Battelle Memorial Institute, Atlanta, GA, (6)Paul Epner Consulting, LLC, Evanston, IL, (7)Arizona State University, Scottsdale, AZ
23
HSR
*
WITHDRAWAL OF IMMUNOSUPPRESSION FOLLOWING PEDIATRIC LIVER TRANSPLANTATION: A MARKOV ANALYSIS
Saeed Mohammad, MD1, Michael S. Yi, M.D.2 and Estella M. Alonso, MD1, (1)Children's Memorial Hospital, Northwestern University, Chicago, IL, (2)University of Cincinnati, Cincinnati, OH OH, USA USA
24
HSR
INPATIENT COSTS OF CORONARY HEART DISEASE AMONG ADULTS AGED 18-64 YEARS
Guijing Wang, PhD, Zhang Zefeng, PhD, Ayala Carma, PhD, Dunet Diane, PhD and Fang Jing, MD, Centers for Disease Control and Prevention, Atlanta, GA
25
HSR
THE ASSOCIATIONS OF MENOPAUSE AND HEALTH-RELATED QUALITY OF LIFE WITH HEALTH SERVICES UTILIZATION: RESULTS FROM THE STRIDE STUDY
Rachel Hess, MD, MS1, Chung-Chou H. Chang, PhD1, Roberta B. Ness, MD, MPH2, Ron D. Hays, PhD3, Wishwa N. Kapoor, MD, MPH1 and Cindy L. Bryce, PhD1, (1)University of Pittsburgh School of Medicine, Pittsburgh, PA, (2)The University of Texas School of Public Health, Houston, TX, (3)University of California, Los Angeles, Los Angeles, CA
27
HSR
*
DESIGNING RISK-TAILORED BREAST CANCER SCREENING POLICIES CONSIDERING IMPERFECT ADHERENCE
Turgay Ayer, MS1, Oguzhan Alagoz, PhD1, Natasha K. Stout, Ph.D.2 and Elizabeth S. Burnside, MD, MPH, MS3, (1)University of Wisconsin, Madison, WI, (2)Department of Population Medicine, Boston, MA, (3)University of Wisconsin-Madison, Madison, WI
28
HSR
RESPIRATORY HOSPITALIZATIONS ASSOCIATED WITH PALIVIZUMAB COMPLIANCE IN THE CANADIAN REGISTRY OF SYNAGIS (CARESS)
Abby Li, M.Sc.1, Bosco A. Paes, MB, BS, FRCPI, FRCPC2, Hadas Benhabib1, Ian Mitchell, MD, FRCPC3 and Krista L. Lanctôt, PhD1, (1)Sunnybrook Health Sciences Centre, Toronto, ON, Canada, (2)McMaster Children's Hospital, Hamilton, ON, Canada, (3)University of Calgary, Calgary, AB, Canada
29
HSP
PHYSICIAN HEAL THYSELF! WHY DO SURGEONS DECIDE TO IGNORE THEIR OWN HEALTH ADVICE?
Beate Hanson, MD, MPH, AO Foundation, Dübendorf, Switzerland, Dirk Stengel, MD, MSc, Unfallkrankenhaus Berlin, Berlin, Germany, Michael Suk, MD, JD, MPH, FACS, University of Florida - Shands Jacksonville, Jacksonville, FL and Jan Ljungqvist, AO Foundation , Dübendorf, Switzerland
30
DEM
THE EFFECT OF RADIOLOGY TRAINING ROUTE AND WORKSTATION LAYOUT ON MAMMOGRAPHY DECISIONS
Sian Taylor-Phillips, PhD1, Matthew G. Wallis, MBChB2, Alison Duncan, MBChB, FRCR3, Aileen Clarke, MBChB1 and Alastair G. Gale, PhD4, (1)The University of Warwick, Coventry, United Kingdom, (2)Addenbrookes Hospital, Cambridge, United Kingdom, (3)University Hospital Coventry and Warwickshire Hospital NHS Trust, Coventry, United Kingdom, (4)Loughborough University, Loughborough, United Kingdom
31
JDM
ASSESSMENT OF DIET-RELATED DECISIONAL CONFLICT IN PATIENTS AND THEIR DIETITIANS
Sophie Desroches, RD, PhD, Université Laval; CHUQ Research Center-Hôpital St-François d'Assise, Quebec, QC, Canada, France Légaré, MD, PhD, CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada and Merlin Njoya, MSc, CHUQ Research Center-Hospital St-François d'Assise, Quebec, QC, Canada
32
JDM
COMMUNICATION ABOUT CANCER PATIENTS' APPRAISAL OF TREATMENT ASPECTS AND ALTERNATIVES: AN EXPLORATIVE STUDY
Arwen H. Pieterse, PhD1, Inge Henselmans, PhD2, Caro C.E. Koning, PhD2, J. (Hanneke) CJM de Haes, PhD2 and Ellen MA Smets, PhD2, (1)Leiden University Medical Center, Leiden, Netherlands, (2)Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
33
JDM
ARE COMPLAINT LETTERS OF PATIENTS HELPFUL TO IMPROVE QUALITY AND SAFETY OF CARE IN A UNIVERSITY HOSPITAL? CONTRIBUTION OF THE INTERNATIONAL PATIENT CLASSIFICATION PATIENT SAFETY 2009
Daniella Randriamanana, MD, Université Paris Descartes-Faculté de médecine- AP-HP, Paris, France and Gwenaelle Vidal-Trecan, MD, PhD, Université Paris Descartes, Faculté de médecine, AP-HP, Paris, France
34
JDM
*
USING THE MEANS-END CHAIN APPROACH TO MAP CONSUMER DECISION MAKING: THE CASE OF NATURAL HEALTH PRODUCTS
Teresa Tsui, BSc(Hon), ND1, Heather Boon, BScPhm, PhD1, Murray D. Krahn, MD, MSc1, Andreas Boecker, MSc, PhD2 and Natasha Kachan, MEd1, (1)University of Toronto, Toronto, ON, Canada, (2)University of Guelph, Guelph, ON, Canada
35
JDM
USING TEST ATTRIBUTES TO DESCRIBE PATIENT PREFERENCES FOR COLON CANCER SCREENING TESTS
Sarah T. Hawley, PhD, MPH, University of Michigan, Ann Arbor VA Health System, Ann Arbor, MI, Sarah E. Lillie, MPH, University of Michigan, Ann Arbor, MI, Nancy Oja-Tebbe, BS, Henry Ford Health System, Detroit, MI and Jennifer Elston Lafata, PhD, Virginia Commonwealth University, Richmond, VA
36
JDM
CONSEQUENCES OF PAYMENT MECHANISMS ON TUBERCULOSIS CONTROL
Ruzanna Grigoryan, MD, MPH, Nune Truzyan, DVM, MPH, Hripsime Martirosyan, MD, MPH, Byron Crape, MSPH, PhD and Varduhi Petrosyan, MS, PhD, American University of Armenia, Yerevan, Armenia
37
JDM
DOES ADOPTION OF CLINICAL PRACTICE GUIDELINES NEGATIVELY AFFECT ADOPTION OF SHARED DECISION MAKING IN PRACTICE?
France Légaré, MD, PhD1, Michel Labrecque, MD, PhD2, Gaston Godin, PhD2, Merlin Njoya, MSc1 and Michel Cauchon, MD2, (1)CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada, (2)Universite Laval, Quebec, QC, Canada
39
JDM
IDENTIFYING AND OVERCOMING BARRIERS TO IMPLEMENTATION OF SHARED DECISION MAKING AND DECISION AIDS
Megan A. Morris, MS, Anne D. Renz, MPH, Douglas A. Conrad, PhD, MBA, MHA and Carolyn A. Watts, PhD, University of Washington, Seattle, WA
40
JDM
UNDERSTANDING THE INFLUENCE OF PATIENT NARRATIVES IN A DECISION AID FOR EARLY STAGE BREAST CANCER
Victoria A. Shaffer, PhD, Department of Psychology, Wichita, KS, Lukas Hulsey, BS, Wichita State University, Wichita, KS and Sara Tomek, PhD, University of Alabama, Tuscaloosa, AL
42
JDM
DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
Carolyn E. Beck, MD, MSc, FRCPC1, Katherine Boydell, PhD1, Vicky Breakey, MD, FRCPC1, Catherine S. Birken, MD, MSc, FRCPC1, Elaine Stasiulis, MA, PhD, (c)1, Victor S. Blanchette, MD, FRCPC1, Hilary A. Llewellyn-Thomas, PhD2 and Patricia C. Parkin, MD, FRCPC1, (1)The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, (2)Dartmouth Medical School, Lebanon, NH
43
JDM
FORECASTING FUNCTIONAL GAINS PLATEAU FOR NEUROREHABILITATION PATIENTS
Tammy Sieminowski, MD, MEng, Bridgepoint Hospital, Toronto, ON, Canada and Michael Carter, PhD, University of Toronto, Toronto, ON, Canada
46
JDM
PHARMACY LOCATION CORRELATION WITH FILLS OF INHALED CORTICOSTEROIDS IN URBAN CHILDREN WITH ASTHMA
C. J. Lewis-Land, MLA, CCRP1, Kevin D. Frick, PhD2, J. M. Walker, MHS1, M. G. Tsoukleris, Pharm, D, BCPS3 and A. M. Butz, ScD, RN1, (1)The Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, MD, (2)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (3)University of Maryland School of Pharmacy, Baltimore, MD
47
JDM
TEACHING MEDICAL DECISION MAKING: A CHALLENGE TO A MEDICAL ASSOCIATION
Patricia Granja, MD, MPH, Public Health Institute. Pontifical Catholic University of Ecuador, Quito, Ecuador and Xavier Maldonado, MD, Family, Practitioner, Medical School, Pontifical University of Ecuador, Quito, Ecuador
48
JDM
EXPLAINING RISK REDUCTIONS TO PATIENTS: DO PHYSICIANS USE NUMBERS?
Peder A. Halvorsen, MD, PhD, University of Tromsø, Tromsø, Norway, Olaf Gjerløw Aasland, MD, PhD, The Norwegian Medical Association, Oslo, Norway and Ivar Sønbø Kristiansen, MD, PhD, University of Oslo, Oslo, Norway
50
JDM
WHY ARE CLINICIANS RELUCTANT TO APPLY THRESHOLD THEORY?
Jef Van den Ende Sr., PhD1, Juan Moreira, MD1 and Zeno Bisoffi, Md2, (1)Institute of Tropical Medicine, Antwerp, Belgium, (2)Centro per le Malattie Tropicali – Ospedale Sacro Cuore, Verona, Italy
52
JDM
RESIDENT PHYSICIANS PERSPECTIVES ON USE OF DECISION SUPPORT AND SHARED DECISION MAKING IN A CLINICAL SETTING
Alison Brenner, MPH1, Shaun N. McDonald, BS2, Christopher DeLeon, MA2, Robert Malone, PharmD2 and Carmen Lewis, MD, MPH2, (1)University of Washington Seattle, Raleigh, NC, (2)University of North Carolina at Chapel Hill, Chapel Hill, NC
53
RFR
A NOVEL USE OF NATURAL LANGUAGE PROCESSING TO ANALYZE MEDICAL DEVICE ADVERSE EVENT REPORTS
Michael S. Broder, MD, MSHS, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, Yang Huang, PhD, MSCS, Kaiser Permanente, Pasadena, CA and Sean O'Neill, M.Phil., Northwestern University, Santa Monica, CA
54
RFR
*
MULTISTAGE VIRTUALLY EXPERIENCED PATIENT DECISION MAKING
Mark D. Horowitz, MS1, Robert B. Allen, Ph.D.2 and Prudence W. Dalrymple, Ph.D.2, (1)Drexel University, Ambler, PA, (2)Drexel University, Philadelphia, PA
55
GLH
PARENTS OF CHILDREN WITH HEALTH PROBLEMS: HOW DOES THEIR HEALTH CHANGE OVER TIME?
Jamie C. Brehaut, PhD1, Rochelle Garner, PhD2, Dafna Kohen, PhD2, Anton Miller, MD3, Lucyna Lach, PhD4, Anne Klassen, DPhil5 and Peter Rosenbaum, MD5, (1)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)Statistics Canada, Ottawa, ON, Canada, (3)University of British Columbia, Vancouver, BC, Canada, (4)McGill University, Montreal, QC, Canada, (5)McMaster University, Hamilton, ON, Canada
56
JDM
CAN IPDAS CRITERIA BE USED TO ASSESS THE QUALITY OF INFORMED CONSENT DOCUMENTS?
Jamie C. Brehaut, PhD1, Kelly Carroll, MA1, Glyn Elwyn, MD, PhD2, Ray Saginur, MD3, Kaveh Shojania, MD4, Jonathan Kimmelman, PhD5 and Dean Fergusson, PhD1, (1)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)Cardiff University, Cardiff, United Kingdom, (3)Ottawa Hospital, Ottawa, ON, Canada, (4)Sunnybrook Health Sciences Centre, Toronto, ON, Canada, (5)McGill University, Montreal, QC, Canada
57
HTA
COST-EFFECTIVENESS ANALYSIS OF DIAGNOSTIC TESTS: AN EXAMPLE STUDY OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY TO DIAGNOSE THE PRESENCE OF ASCENDING AORTIC ATHEROSCLEROSIS IN CARDIAC SURGERY PATIENTS
H. Koffijberg, PhD1, B. van Zaane, MD, PhD1, A.P. Nierich, MD, PhD2 and K.G.M. Moons, PhD1, (1)University Medical Center Utrecht, Utrecht, Netherlands, (2)Isala Clinics, Zwolle, Netherlands
58
JDM
COMMUNICATING UNCERTAINTY IN GENERALIZED COST-EFFECTIVENESS ANALYSES: VISUALIZING OPTIMAL INTERVENTIONS AND STRATEGIES
H. Koffijberg, PhD, University Medical Center Utrecht, Utrecht, Netherlands, G.A. de Wit, PhD, National Institute for Public Health and the Environment, Bilthoven, Netherlands and T. Feenstra, PhD, University Medical Center Groningen, Groningen, Netherlands
59
RFR
APPLICATION OF ESTIMATION AND PROJECTION PACKAGE TO THE CONTEXT OF AUSTRALIA'S HIV EPIDEMIC
Hla-Hla Thein, MD, MPH, PhD1, Lei Zhang, PhD2 and David Wilson, PhD2, (1)University of New South Wales and University of Toronto, Sydney, Australia, (2)University of New South Wales, Sydney, Australia
